Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,522 papers from all fields of science
Search
Sign In
Create Free Account
Rz967
Known as:
hammerhead ribozyme Rz967
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Catalytic RNA
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
L. Ye
,
J. Lewis-Russell
,
H. Kynaston
,
W. Jiang
Journal of Urology
2007
Corpus ID: 31486593
Highly Cited
2002
Highly Cited
2002
A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
J. Murray
,
C. Dunham
,
W. Scott
Journal of Molecular Biology
2002
Corpus ID: 18102624
We have investigated the chemical basis for a previously observed 7.8 A conformational change in the hammerhead ribozyme that…
Expand
Highly Cited
2002
Highly Cited
2002
Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2
Petra Kowalski
,
U. Stein
,
G. Scheffer
,
H. Lage
Cancer Gene Therapy
2002
Corpus ID: 33738117
The phenomenon of multidrug resistance (MDR) in human cancers is one of the major causes of failure of chemotherapy. A recently…
Expand
Highly Cited
2001
Highly Cited
2001
Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Antje Ludwig
,
G. Saretzki
,
+5 authors
T. Zglinicki
Cancer Research
2001
Corpus ID: 25489772
Telomerase activity is necessary and sufficient for immortality in many cells and hence represents a prime target for antitumor…
Expand
2001
2001
Functional disruption of IEX‐1 expression by concatemeric hammerhead ribozymes alters growth properties of 293 cells
Olaf Grobe
,
Alexander Arlt
,
+4 authors
H. Schäfer
FEBS Letters
2001
Corpus ID: 37738931
Highly Cited
1997
Highly Cited
1997
Development of a hammerhead ribozyme against bcl‐2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone‐refractory human prostate cancer
T. Dorai
,
C. Olsson
,
A. Katz
,
R. Buttyan
The Prostate
1997
Corpus ID: 29899485
The bcl‐2 oncoprotein suppresses apoptosis and, when overexpressed in prostate cancer cells, makes these cells resistant to a…
Expand
Highly Cited
1997
Highly Cited
1997
The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.
R. Hormes
,
Matthias Homann
,
+4 authors
George Sczakiel
Nucleic Acids Research
1997
Corpus ID: 14957209
The length requirements of the antisense portion of hammerhead ribozymes for efficacy in living cells was investigated. The HIV…
Expand
Highly Cited
1997
Highly Cited
1997
Hammerhead ribozymes with a faster cleavage rate.
B. Clouet-d’Orval
,
O. Uhlenbeck
Biochemistry
1997
Corpus ID: 31601481
A hammerhead ribozyme that was previously reported to have a rate of chemical cleavage 10-fold faster than that of conventional…
Expand
Highly Cited
1996
Highly Cited
1996
Rescue of abasic hammerhead ribozymes by exogenous addition of specific bases.
Alessio Peracchi
,
Leonid Beigelman
,
Nassim Usman
,
Daniel Herschlag
Proceedings of the National Academy of Sciences…
1996
Corpus ID: 6154017
We have synthesized 13 hammerhead ribozyme variants, each containing an abasic residue at a specific position of the catalytic…
Expand
Highly Cited
1996
Highly Cited
1996
The ion-induced folding of the hammerhead ribozyme: core sequence changes that perturb folding into the active conformation.
Gurminder S. Bassi
,
A. Murchie
,
David M. J. Lilley
RNA: A publication of the RNA Society
1996
Corpus ID: 35200015
The hammerhead ribozyme undergoes an ion-dependent folding process into the active conformation. We find that the folding can be…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE